Browse Studies — Arctuva

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of DYNE-251 Administered Intravenously in Ambulatory Male Participants 4 to 18 Years of Age With Duchenne Muscular Dystrophy Amenable to Exon-51 Skipping

The purpose of the study is to assess the efficacy, safety, and tolerability of zeleciment rostudirsen (DYNE-251) administered intravenously (IV) every 4 weeks…

Duchenne Muscular Dystrophy (DMD)Muscular Dystrophy, DuchenneMuscular Dystrophy (DMD)+10 more

Estimated

~$10 – $8,750

Dyne TherapeuticsNCT07608432

Northwestern Neuromuscular Disease Biorepository

The primary objective of this research is to collect clinical data and tissue samples from adult patients with neuromuscular disease cared for at the Northwest…

Neuromuscular Diseases (NMD)

Estimated

~$10 – $750

Northwestern UniversityNCT07477509

Observational

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults withNeuromuscular Disease

This single-arm pilot study evaluates the effects of whole-body electrical muscle stimulation (WB-EMS) exercise on neuromuscular and physical function in adult…

Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more

Estimated

~$10 – $6,250

University of Missouri-ColumbiaNCT07478172